Please enable JavaScript to continue using this application.

Compare $GOSS vs $RNXT | Chartloom

Compare

$GOSS vs $RNXT

Gossamer Bio Inc · RenovoRx Inc

GOSS

Gossamer Bio Inc

RNXT

RenovoRx Inc

Compare $GOSS vs $RNXT

Comparing Gossamer Bio Inc and RenovoRx Inc

GOSSGossamer Bio Inc

RNXTRenovoRx Inc

GOSSGossamer Bio Inc

Market cap

$4.55B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

32.4%

YTD performance

-96.0%

52W performance

-95.2%

FCF yield

-3.6%

RNXTRenovoRx Inc

Market cap

$58M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

8.70x

Rev growth (TTM)

198.5%

YTD performance

53.3%

52W performance

5.8%

FCF yield

-20.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GOSS

RNXT

Detailed metrics comparison

GOSS

Gossamer Bio Inc

RNXT

RenovoRx Inc

Market Cap

GOSS$4.55B

RNXT$58M

Enterprise Value

GOSS$4.55B

RNXT$48M

Price

GOSS$9.31

RNXT$1.28

P/E Ratio

GOSSN/A

RNXTN/A

P/S Ratio

GOSS85.41x

RNXT29.18x

EV/Sales

GOSS85.32x

RNXT24.39x

EV/EBITDA

GOSS0.00x

RNXT0.00x

P/B Ratio

GOSS2.26x

RNXT7.94x

P/FCF Ratio

GOSSN/A

RNXTN/A

EV/FCF

GOSS-27.95x

RNXT-4.04x

PEG Ratio

GOSSN/A

RNXTN/A

Forward P/E (NTM)

GOSSN/A

RNXTN/A

Forward P/S (NTM)

GOSSN/A

RNXT8.70x

Revenue (TTM)

GOSS$53M

RNXT$2M

Revenue Growth (YoY)

GOSS32.4%

RNXT198.5%

Forward Rev Growth

GOSS50.5%

RNXT195.2%

Gross Margin (TTM)

GOSS0.0%

RNXT84.4%

Operating Margin (TTM)

GOSS0.0%

RNXT0.0%

EBITDA Margin (TTM)

GOSS-297.6%

RNXT-684.9%

Net Margin (TTM)

GOSS-235.0%

RNXT-621.7%

FCF Margin (TTM)

GOSS-305.2%

RNXT-604.1%

Net Income (TTM)

GOSS$-125M

RNXT$-12M

FCF (TTM)

GOSS$-163M

RNXT$-12M

EPS (TTM)

GOSS-$0.38

RNXT-$0.26

ROE (TTM)

GOSS-11877.0%

RNXT-14563.0%

ROA (TTM)

GOSS-8535.0%

RNXT-10984.0%

ROIC (TTM)

GOSS-2300.0%

RNXT-14563.0%

Cash

GOSS$41M

RNXT$9M

Debt

GOSS$36M

RNXT$0

Net Cash/Debt

GOSS$5M

RNXT$9M

Current Ratio (TTM)

GOSS0.53x

RNXT5.74x

Quick Ratio (TTM)

GOSS0.46x

RNXT5.37x

Debt/Equity (TTM)

GOSS6.83x

RNXT0.00x

Debt/Assets (TTM)

GOSS0.0%

RNXT0.0%

Interest Coverage (TTM)

GOSSN/A

RNXTN/A

Net Debt/EBITDA (TTM)

GOSS0.00x

RNXT0.00x

Beta

GOSS2.28

RNXT1.07

52W Performance

GOSS-95.2%

RNXT5.8%

YTD Performance

GOSS-96.0%

RNXT53.3%

% from 52W High

GOSS-97.0%

RNXT-50.6%

% from 52W Low

GOSS2.3%

RNXT82.7%

Asset Turnover (TTM)

GOSS0.36x

RNXT0.18x

FCF Yield (TTM)

GOSS-3.6%

RNXT-20.7%

Earnings Yield (TTM)

GOSS-2.8%

RNXT-21.3%

Dividend Yield (TTM)

GOSSN/A

RNXTN/A

Rule of 40

GOSS-272.8

RNXT-405.6

EV/GP/RG

GOSSN/A

RNXT0.12

Ticker research

View GOSS research View RNXT research

Metric	GOSS Gossamer Bio Inc	RNXT RenovoRx Inc
Market & Valuation
Market Cap	$4.55B	$58M
Enterprise Value	$4.55B	$48M
Price	$9.31	$1.28
P/E Ratio	N/A	N/A
P/S Ratio	85.41x	29.18x
EV/Sales	85.32x	24.39x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.26x	7.94x
P/FCF Ratio	N/A	N/A
EV/FCF	-27.95x	-4.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	8.70x
Revenue & Growth
Revenue (TTM)	$53M	$2M
Revenue Growth (YoY)	32.4%	198.5%
Forward Rev Growth	50.5%	195.2%
Profitability
Gross Margin (TTM)	0.0%	84.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-297.6%	-684.9%
Net Margin (TTM)	-235.0%	-621.7%
FCF Margin (TTM)	-305.2%	-604.1%
Net Income (TTM)	$-125M	$-12M
FCF (TTM)	$-163M	$-12M
EPS (TTM)	-$0.38	-$0.26
ROE (TTM)	-11877.0%	-14563.0%
ROA (TTM)	-8535.0%	-10984.0%
ROIC (TTM)	-2300.0%	-14563.0%
Financial Health
Cash	$41M	$9M
Debt	$36M	$0
Net Cash/Debt	$5M	$9M
Current Ratio (TTM)	0.53x	5.74x
Quick Ratio (TTM)	0.46x	5.37x
Debt/Equity (TTM)	6.83x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.28	1.07
52W Performance	-95.2%	5.8%
YTD Performance	-96.0%	53.3%
% from 52W High	-97.0%	-50.6%
% from 52W Low	2.3%	82.7%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.18x
FCF Yield (TTM)	-3.6%	-20.7%
Earnings Yield (TTM)	-2.8%	-21.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-272.8	-405.6
EV/GP/RG	N/A	0.12
Ticker research	View GOSS research	View RNXT research

Valuation

P/S Ratio

RNXT

29.18x

GOSS

85.41x

EV/FCF

GOSS

-27.95x

RNXT

-4.04x

Growth & revenue

Revenue Growth TTM

RNXT

198.5%

GOSS

32.4%

Forward Revenue Growth

RNXT

195.2%

GOSS

50.5%

Profitability & performance

Gross Margin

RNXT

84.4%

GOSS

0.0%

ROE

GOSS

-11877.0%

RNXT

-14563.0%

FCF Yield %

GOSS

-3.6%

RNXT

-20.7%

52-Week Performance

RNXT

5.8%

GOSS

-95.2%

Detailed metrics comparison

GOSS

Gossamer Bio Inc

RNXT

RenovoRx Inc

Market Cap

GOSS$4.55B

RNXT$58M

Enterprise Value

GOSS$4.55B

RNXT$48M

Price

GOSS$9.31

RNXT$1.28

P/E Ratio

GOSSN/A

RNXTN/A

P/S Ratio

GOSS85.41x

RNXT29.18x

EV/Sales

GOSS85.32x

RNXT24.39x

EV/EBITDA

GOSS0.00x

RNXT0.00x

P/B Ratio

GOSS2.26x

RNXT7.94x

P/FCF Ratio

GOSSN/A

RNXTN/A

EV/FCF

GOSS-27.95x

RNXT-4.04x

PEG Ratio

GOSSN/A

RNXTN/A

Forward P/E (NTM)

GOSSN/A

RNXTN/A

Forward P/S (NTM)

GOSSN/A

RNXT8.70x

Revenue (TTM)

GOSS$53M

RNXT$2M

Revenue Growth (YoY)

GOSS32.4%

RNXT198.5%

Forward Rev Growth

GOSS50.5%

RNXT195.2%

Gross Margin (TTM)

GOSS0.0%

RNXT84.4%

Operating Margin (TTM)

GOSS0.0%

RNXT0.0%

EBITDA Margin (TTM)

GOSS-297.6%

RNXT-684.9%

Net Margin (TTM)

GOSS-235.0%

RNXT-621.7%

FCF Margin (TTM)

GOSS-305.2%

RNXT-604.1%

Net Income (TTM)

GOSS$-125M

RNXT$-12M

FCF (TTM)

GOSS$-163M

RNXT$-12M

EPS (TTM)

GOSS-$0.38

RNXT-$0.26

ROE (TTM)

GOSS-11877.0%

RNXT-14563.0%

ROA (TTM)

GOSS-8535.0%

RNXT-10984.0%

ROIC (TTM)

GOSS-2300.0%

RNXT-14563.0%

Cash

GOSS$41M

RNXT$9M

Debt

GOSS$36M

RNXT$0

Net Cash/Debt

GOSS$5M

RNXT$9M

Current Ratio (TTM)

GOSS0.53x

RNXT5.74x

Quick Ratio (TTM)

GOSS0.46x

RNXT5.37x

Debt/Equity (TTM)

GOSS6.83x

RNXT0.00x

Debt/Assets (TTM)

GOSS0.0%

RNXT0.0%

Interest Coverage (TTM)

GOSSN/A

RNXTN/A

Net Debt/EBITDA (TTM)

GOSS0.00x

RNXT0.00x

Beta

GOSS2.28

RNXT1.07

52W Performance

GOSS-95.2%

RNXT5.8%

YTD Performance

GOSS-96.0%

RNXT53.3%

% from 52W High

GOSS-97.0%

RNXT-50.6%

% from 52W Low

GOSS2.3%

RNXT82.7%

Asset Turnover (TTM)

GOSS0.36x

RNXT0.18x

FCF Yield (TTM)

GOSS-3.6%

RNXT-20.7%

Earnings Yield (TTM)

GOSS-2.8%

RNXT-21.3%

Dividend Yield (TTM)

GOSSN/A

RNXTN/A

Rule of 40

GOSS-272.8

RNXT-405.6

EV/GP/RG

GOSSN/A

RNXT0.12

Ticker research

View GOSS research View RNXT research

Metric	GOSS Gossamer Bio Inc	RNXT RenovoRx Inc
Market & Valuation
Market Cap	$4.55B	$58M
Enterprise Value	$4.55B	$48M
Price	$9.31	$1.28
P/E Ratio	N/A	N/A
P/S Ratio	85.41x	29.18x
EV/Sales	85.32x	24.39x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.26x	7.94x
P/FCF Ratio	N/A	N/A
EV/FCF	-27.95x	-4.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	8.70x
Revenue & Growth
Revenue (TTM)	$53M	$2M
Revenue Growth (YoY)	32.4%	198.5%
Forward Rev Growth	50.5%	195.2%
Profitability
Gross Margin (TTM)	0.0%	84.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-297.6%	-684.9%
Net Margin (TTM)	-235.0%	-621.7%
FCF Margin (TTM)	-305.2%	-604.1%
Net Income (TTM)	$-125M	$-12M
FCF (TTM)	$-163M	$-12M
EPS (TTM)	-$0.38	-$0.26
ROE (TTM)	-11877.0%	-14563.0%
ROA (TTM)	-8535.0%	-10984.0%
ROIC (TTM)	-2300.0%	-14563.0%
Financial Health
Cash	$41M	$9M
Debt	$36M	$0
Net Cash/Debt	$5M	$9M
Current Ratio (TTM)	0.53x	5.74x
Quick Ratio (TTM)	0.46x	5.37x
Debt/Equity (TTM)	6.83x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.28	1.07
52W Performance	-95.2%	5.8%
YTD Performance	-96.0%	53.3%
% from 52W High	-97.0%	-50.6%
% from 52W Low	2.3%	82.7%
Efficiency & Yields
Asset Turnover (TTM)	0.36x	0.18x
FCF Yield (TTM)	-3.6%	-20.7%
Earnings Yield (TTM)	-2.8%	-21.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-272.8	-405.6
EV/GP/RG	N/A	0.12
Ticker research	View GOSS research	View RNXT research